Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial evaluating metronomic capecitabine with or without a PD-1 antibody as adjuvant therapy for high-risk nasopharyngeal carcinoma;…
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial exploring PD-1 blockade and bevacizumab as a substitute for cisplatin in locoregionally advanced nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-04-18Clinical Trial Update: The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer [Phase 3]
This entry reports the results of a Phase 3 study evaluating toripalimab plus chemotherapy in recurrent or metastatic nasopharyngeal carcino…
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy [Phase 2]
Phase 2 trial evaluating anti-EGFR therapy with IMRT concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma resistant to…
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating immunotherapy combined with chemotherapy in unresectable recurrent loco-regionally advanced nasopharyngeal carcinom…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC [Phase 3]
Phase 3 trial evaluating sequential or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin [Phase 2]
Phase 2 trial updating chemoradiotherapy with raltitrexed-cisplatin for locally advanced nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial comparing Endostar plus intensity-modulated radiotherapy to chemoradiation for nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 study evaluating anlotinib in combination with chemoradiation for locally advanced nasopharyngeal carcinoma; current status is unkno…
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: PD-1 Inhibitor Plus G-CSF in Recurrent/Metastatic NPC With First-line Treatment Failure [Phase 2]
Phase 2 trial update evaluating a PD-1 inhibitor with G-CSF as first-line treatment failure in recurrent/metastatic nasopharyngeal carcinoma…
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating Endostar in combination with corticosteroids for radiation-induced brain necrosis in nasopharyngeal carcin…
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: Niraparib And Sintilimab In Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial update evaluating niraparib plus sintilimab in recurrent/metastatic nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122/KEYNOTE-122) [Phase 3]
Phase 3 trial of pembrolizumab in platinum-pretreated recurrent/metastatic nasopharyngeal cancer completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating toripalimab (JS001) in advanced gastric cancer and multiple squamous cell carcinomas including esophagea…
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: Individualized Elective Neck Irradiation Based on MRI in NPC Patients [Phase 3]
Phase 3 trial evaluating individualized elective neck irradiation based on MRI in nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating proton radiotherapy with chemotherapy for nasopharyngeal carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Tirelizumab Plus Surgery vs Surgery Alone for Recurrent Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 trial evaluating tirelizumab plus surgery versus surgery alone for recurrent nasopharyngeal carcinoma is ongoing with status not s…
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: ICCRT vs. CRT for Locally Advanced Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial comparing ICCRT versus CRT for locally advanced nasopharyngeal carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2021-08-30Clinical Trial Update: A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial evaluating four cycles of neoadjuvant chemotherapy followed by concurrent chemoradiation in N2-3 nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy [Phase 2]
Phase 2 clinical trial evaluating the impact on xerostomia in nasopharyngeal carcinoma patients treated with or without superficial parotid …
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: SHR-1701 in Combination With Famitinib in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma [Phase 1, Phase 2]
Clinical trial update for SHR-1701 combined with famitinib in recurrent/metastatic nasopharyngeal carcinoma (Phase 1/Phase 2) with status cu…
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating reduced-dose radiotherapy in low-risk stage III nasopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-08-20Clinical Trial Update: Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial [Phase 2]
A Phase II prospective single-arm study evaluating concurrent chemoradiotherapy with toripalimab for locally recurrent nasopharyngeal carcin…
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial assessing safety and efficacy of PDR001 in recurrent or metastatic nasopharyngeal carcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating surufatinib combined with toripalimab in recurrent or metastatic nasopharyngeal carcinoma.